Literature DB >> 20836090

Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression.

Philippe Riou1, Priam Villalonga, Anne J Ridley.   

Abstract

Rnd3/RhoE has two distinct functions, regulating the actin cytoskeleton and cell proliferation. This might explain why its expression is often altered in cancer and by multiple stimuli during development and disease. Rnd3 together with its relatives Rnd1 and Rnd2 are atypical members of the Rho GTPase family in that they do not hydrolyse GTP. Rnd3 and Rnd1 both antagonise RhoA/ROCK-mediated actomyosin contractility, thereby regulating cell migration, smooth muscle contractility and neurite extension. In addition, Rnd3 has been shown to have a separate role in inhibiting cell cycle progression by reducing translation of cell cycle regulators, including cyclin D1 and Myc. We propose that Rnd3 could act as a tumour suppressor to limit proliferation, but when mutations bypass this activity of Rnd3, it can promote cancer invasion through its effects in the actin cytoskeleton.
Copyright © 2010 WILEY Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836090     DOI: 10.1002/bies.201000060

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  48 in total

1.  Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.

Authors:  Paola Ostano; Silvia Bione; Cristina Belgiovine; Ilaria Chiodi; Chiara Ghimenti; A Ivana Scovassi; Giovanna Chiorino; Chiara Mondello
Journal:  OMICS       Date:  2012 Jan-Feb

2.  RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.

Authors:  Guo Xiang; Yang Yi; He Weiwei; Wu Weiming
Journal:  Tumour Biol       Date:  2015-08-07

Review 3.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  The Rho family member RhoE interacts with Skp2 and is degraded at the proteasome during cell cycle progression.

Authors:  Marta Lonjedo; Enric Poch; Enric Mocholí; Marta Hernández-Sánchez; Carmen Ivorra; Thomas F Franke; Rosa M Guasch; Ignacio Pérez-Roger
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

5.  Active GTPase Pulldown Protocol.

Authors:  Martin J Baker; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

6.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.

Authors:  Hui Zhao; Jianping Yang; Tianli Fan; Shenglei Li; Xuequn Ren
Journal:  Tumour Biol       Date:  2012-04-03

7.  The GTPase-deficient Rnd proteins are stabilized by their effectors.

Authors:  Liuh Ling Goh; Ed Manser
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

8.  Analysis of RhoE expression in the testis, epididymis and ductus deferens, and the effects of its deficiency in mice.

Authors:  Olga Gómez; Begoña Ballester-Lurbe; Rosa M Guasch; Ignacio Pérez-Roger; Empar García-Roselló; José Terrado
Journal:  J Anat       Date:  2014-10-01       Impact factor: 2.610

Review 9.  Regulating Rho GTPases and their regulators.

Authors:  Richard G Hodge; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-15       Impact factor: 94.444

Review 10.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.